Paul Hastings, a leading global law firm, announced today that it represented Haitong International Securities Group Limited (“Haitong International”), a subsidiary of Haitong Securities Co., Ltd., which is the second largest securities firm in China by total assets, in its HK$1.17 billion rights issue. One rights share for every two existing shares was offered at HK$2.55 per rights share.
Tags: Paul Hastings, LLP | Hong Kong
The Charleston office of global law firm K&L Gates LLP welcomes Michael D. Bryan and Julius H. “Sam” Hines as partners in the corporate/M&A and commercial disputes practices, respectively. Bryan joins K&L Gates from Nelson Mullins Riley & Scarborough LLP, where he chaired the firm’s sustainable energy group, while Hines arrives from Womble Carlyle Sandridge & Rice, LLP, where he was a leader of the firm’s admiralty and maritime practice group.
Tags: K&L Gates LLP
Leading international law firm Clifford Chance has advised Capital Dynamics on its strategic cooperation agreement with China-based fund of funds manager Diligence Capital. The partnership will enable Capital Dynamics to join its long-standing global scope and infrastructure in private equity with Diligence Capital’s local knowledge and expertise so as to enhance both parties’ business in the Greater China region.
Tags: Clifford Chance LLP | Hong KongLeading international law firm Clifford Chance has advised Australia’s Toga Group on a 50:50 joint venture in hotel management and ownership with Singapore’s Far East Orchard Limited.
Tags: Clifford Chance LLP | SingaporeClifford Chance advised European Aeronautic Defence and Space Company EADS N.V. and its subsidiary EADS Finance B.V. on its debut US bond issue with an issue volume of USD 1 billion. The bonds were issued by EADS Finance B.V. primarily to US institutional investors pursuant to Rule 144A and were irrevocably and unconditionally guaranteed by the Dutch listed holding company European Aeronautic Defence and Space Company EADS N.V. J.P. Morgan, Barclays, Citigroup, Morgan Stanley and RBS acted as joint Book-Running Managers.
Tags: Clifford Chance LLP
King & Spalding has recruited Peter Megens, one of Australia’s leading international arbitration and construction lawyers, as a partner in its Singapore office. Megens will join King & Spalding from King & Wood Mallesons in Melbourne, Australia, where he is co-head of that firm’s arbitration practice and a senior member of its construction team. Megens is expected to arrive at King & Spalding in July.
Tags: King & Spalding LLP | Singapore
William Scott Matney has joined Porter Hedges as a partner in the Litigation Practice Group. Scott’s practice focuses on commercial litigation, arbitration and mediation.
Tags: Porter Hedges LLP | Houston
Davis Polk advised Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives of the several underwriters in connection with an SEC-registered offering by The Hartford Financial Services Group, Inc. (The Hartford) of $300 million of 4.3% senior notes due 2043.
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk advised Barclays Bank PLC, CITIC Securities Corporate Finance (HK) Limited, The Hongkong and Shanghai Banking Corporation Limited, Morgan Stanley & Co. International plc, UBS AG, Hong Kong Branch and Industrial and Commercial Bank of China (Asia) Limited as joint lead managers in connection with a Regulation S offering by Asia Standard International Group Limited of CNY500 million aggregate principal amount of 6.5% senior notes due 2018 under its US$1 billion Medium Term Note Programme. Davis Polk also advised Morgan Stanley as arranger and Morgan Stanley and UBS as initial dealers in connection with the establishment by Asia Standard of the MTN Programme, of which the underlying documents are governed by English law.
Tags: Davis Polk & Wardwell LLP | Hong KongDavis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC and Jefferies LLC as representatives of the several underwriters in connection with the SEC-registered follow-on offering of 8,222,500 shares of common stock of Durata Therapeutics, Inc., including 1,072,500 shares from the full exercise of the underwriters’ option to purchase additional shares, for a price to the public of approximately $57.6 million.
Tags: Davis Polk & Wardwell LLP | New York